当前位置:
X-MOL 学术
›
ACS Biomater. Sci. Eng.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Nanomedicine Assembled by Coordinated Selenium–Platinum Complexes Can Selectively Induce Cytotoxicity in Cancer Cells by Targeting the Glutathione Antioxidant Defense System
ACS Biomaterials Science & Engineering ( IF 5.4 ) Pub Date : 2017-08-07 00:00:00 , DOI: 10.1021/acsbiomaterials.7b00362 Feng Li 1 , Tianyu Li 1 , Xuexiang Han 2, 3 , Hao Zhuang 1 , Guangjun Nie 2, 3 , Huaping Xu 1
ACS Biomaterials Science & Engineering ( IF 5.4 ) Pub Date : 2017-08-07 00:00:00 , DOI: 10.1021/acsbiomaterials.7b00362 Feng Li 1 , Tianyu Li 1 , Xuexiang Han 2, 3 , Hao Zhuang 1 , Guangjun Nie 2, 3 , Huaping Xu 1
Affiliation
Selenium is a unique, essential trace element that plays an important role in the antioxidant defense and redox regulation of biological processes. We have reported that novel selenium-containing platinum-based anticancer molecules (EG-Se/Pt) had selective cytotoxicity toward cancer cells. Herein, we found the underlying mechanism of selective cytotoxicity to be closely related to the glutathione antioxidant defense system. Elevated reactive oxygen species (ROS) make cancer cells more vulnerable to further elevation of ROS. EG-Se/Pt can induce abnormal increases in ROS by depletion of glutathione. Consequently, the mitochondrial membrane potential collapses and cytochrome c is released, resulting in cell apoptosis. However, EG-Se/Pt analogues, such as EG-Se/Cu and EG-Se/Ni, did not exhibit glutathione depletion capacity or selective killing activity in our investigation, although they can effectively kill cancer cells. These results suggest that the glutathione antioxidant system is an effective target to enable therapeutic selectivity. The amphiphilic property of the selenium–platinum coordination molecules facilitates their assembly into nanoparticles and prolongs the circulation time of the drug in the bloodstream, which is important for in vivo drug delivery. Our in vivo anticancer study demonstrated that the tumor growth inhibition rate of EG-Se/Pt can reach 69% (p < 0.05). What is more encouraging is that EG-Se/Pt exhibited minimal side effects compared to cisplatin. This work also provides new opportunities for the development of therapeutic strategies against cancer.
中文翻译:
硒-铂配合物组装的纳米药物可以通过靶向谷胱甘肽抗氧化防御系统选择性地诱导癌细胞的细胞毒性。
硒是一种独特的必需微量元素,在生物过程的抗氧化剂防御和氧化还原调节中起着重要作用。我们已经报道了新型的基于硒的铂基抗癌分子(EG-Se / Pt)对癌细胞具有选择性的细胞毒性。在这里,我们发现选择性细胞毒性的潜在机制与谷胱甘肽抗氧化剂防御系统密切相关。升高的活性氧(ROS)使癌细胞更容易受到ROS进一步升高的影响。EG-Se / Pt可以通过消耗谷胱甘肽来引起ROS异常增加。因此,线粒体膜电位崩溃并释放出细胞色素c,导致细胞凋亡。但是,EG-Se / Pt类似物,例如EG-Se / Cu和EG-Se / Ni,尽管我们可以有效杀死癌细胞,但在我们的研究中并未显示出谷胱甘肽耗竭能力或选择性杀伤活性。这些结果表明,谷胱甘肽抗氧化剂系统是实现治疗选择性的有效靶标。硒-铂配位分子的两亲性质有利于它们组装成纳米颗粒,并延长了药物在血流中的循环时间,这对于体内药物递送很重要。我们的体内抗癌研究表明,EG-Se / Pt的肿瘤生长抑制率可以达到69%(硒-铂配位分子的两亲性质有利于它们组装成纳米颗粒,并延长了药物在血流中的循环时间,这对于体内药物递送很重要。我们的体内抗癌研究表明,EG-Se / Pt的肿瘤生长抑制率可以达到69%(硒-铂配位分子的两亲性质有利于它们组装成纳米颗粒,并延长了药物在血流中的循环时间,这对于体内药物递送很重要。我们的体内抗癌研究表明,EG-Se / Pt的肿瘤生长抑制率可以达到69%(p<0.05)。令人鼓舞的是,与顺铂相比,EG-Se / Pt的副作用最小。这项工作还为开发抗癌治疗策略提供了新的机会。
更新日期:2017-08-07
中文翻译:
硒-铂配合物组装的纳米药物可以通过靶向谷胱甘肽抗氧化防御系统选择性地诱导癌细胞的细胞毒性。
硒是一种独特的必需微量元素,在生物过程的抗氧化剂防御和氧化还原调节中起着重要作用。我们已经报道了新型的基于硒的铂基抗癌分子(EG-Se / Pt)对癌细胞具有选择性的细胞毒性。在这里,我们发现选择性细胞毒性的潜在机制与谷胱甘肽抗氧化剂防御系统密切相关。升高的活性氧(ROS)使癌细胞更容易受到ROS进一步升高的影响。EG-Se / Pt可以通过消耗谷胱甘肽来引起ROS异常增加。因此,线粒体膜电位崩溃并释放出细胞色素c,导致细胞凋亡。但是,EG-Se / Pt类似物,例如EG-Se / Cu和EG-Se / Ni,尽管我们可以有效杀死癌细胞,但在我们的研究中并未显示出谷胱甘肽耗竭能力或选择性杀伤活性。这些结果表明,谷胱甘肽抗氧化剂系统是实现治疗选择性的有效靶标。硒-铂配位分子的两亲性质有利于它们组装成纳米颗粒,并延长了药物在血流中的循环时间,这对于体内药物递送很重要。我们的体内抗癌研究表明,EG-Se / Pt的肿瘤生长抑制率可以达到69%(硒-铂配位分子的两亲性质有利于它们组装成纳米颗粒,并延长了药物在血流中的循环时间,这对于体内药物递送很重要。我们的体内抗癌研究表明,EG-Se / Pt的肿瘤生长抑制率可以达到69%(硒-铂配位分子的两亲性质有利于它们组装成纳米颗粒,并延长了药物在血流中的循环时间,这对于体内药物递送很重要。我们的体内抗癌研究表明,EG-Se / Pt的肿瘤生长抑制率可以达到69%(p<0.05)。令人鼓舞的是,与顺铂相比,EG-Se / Pt的副作用最小。这项工作还为开发抗癌治疗策略提供了新的机会。